Results 81 to 90 of about 28,214,434 (299)
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic +10 more
wiley +1 more source
Using Cost Effectiveness Analysis; a Beginners Guide
Objective - To describe the key elements of cost effectiveness analysis (CEA) and demonstrate how such analysis may be used in the library environment.
Claire Hulme
doaj +3 more sources
Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir +9 more
wiley +1 more source
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease [PDF]
When choosing between mutually exclusive treatment options, it is common to construct a cost-effectiveness frontier on the cost-effectiveness plane that represents efficient points from among the treatment choices.
Goeree, R. +7 more
core +1 more source
This paper shows that size‐exclusion chromatography and sequential centrifugation applied to seminal plasma enrich for different populations of extracellular vesicles. This may significantly affect the detection and analysis of extracellular vesicle‐associated cancer biomarkers.
Elen Telumyan +8 more
wiley +1 more source
Cost and cost-effectiveness guidelines: which ones to use? [PDF]
Given the increased awareness of the importance of cost-effectiveness in health care, there has been a growth in the number of published economic evaluations in recent years.
Walker, D
core +1 more source
Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS)
Background Treatment cost and high prevalence of Poly Cystic Ovarian Syndrome (PCOS) is a very challenging issue globally. Due to this reason; current study was conducted to determine pharmaco-economy of conventional and non-conventional treatments for ...
Darakhshan Masroor +4 more
doaj +1 more source
Jessica Keim-Malpass,1– 3 H Charles Malpass4 1University of Virginia School of Nursing, Charlottesville, VA, USA; 2Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA, USA; 3University of Virginia Center for Advanced ...
Keim-Malpass J, Malpass HC
doaj
Cost-effectiveness of glaucoma management with monotherapy medications in Egypt
Glaucoma is a serious chronic ophthalmic disease since it causes irreversible visual disability if untreated can lead to blindness. Treatment options include medications (classified into five major classes of drugs which are muscarinic cholinergic ...
Amal Abd-Elaal El-Khamery +3 more
doaj +1 more source
Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma
Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara +10 more
wiley +1 more source

